Exchange transfusion
•
Severe
or rapidly rising hyperbilirubinaemia, e.g. due to severe rhesus or other
haemolytic disease.
•
Cardiac
failure secondary to severe anaemia (with normal or increased plasma volume),
e.g. hydrops fetalis due to rhesus haemolytic disease.
•
Disseminated
intravascular coagulation.
•
Polycythaemia
with a venous haematocrit >70% and/or symptomatic.
•
Acute
poisoning, including that due to metabolic disease.
Exchange is achieved by
sequentially removing 10–15mL of blood from the child and then infusing warmed
(37°), cross-matched, fresh (<72hr old), rhesus –ve, cytomegalovirus (CMV)
–ve, irradiated or leucocyte fil-tered (to prevent graft vs. host disease),
partially packed or whole blood. Exchange transfusion can be performed by
either both withdrawing and then infusing blood via a single central venous
catheter (e.g. umbilicus venous catheter), or withdrawing blood via a central
catheter (arterial or venous) or peripheral arterial catheter and replacing it
via a second central or peripheral venous catheter.
Blood volume (mL) to remove and
then replace (i.e. exchange) is:
•
Severe
anaemia with hydrops requires a single
volume exchange, i.e. 80mL/kg body weight. Should be performed over a
minimum of 1hr.
•
Removal
of toxins, e.g. bilirubin or ammonia, requires a double volume exchange, i.e. 160mL/kg in newborns. This replaces
790% of total blood volume and should be performed over a minimum of 2hr.
•
To
treat polycythaemia, a dilutional exchange transfusion is performed. The
required exchange volume depends on the haematocrit (Hct) and can be calculated
using the formula:
Volume = [measured Hct – desired
Hct] x blood volume measured Hct
•
In a
dilutional exchange replace blood with 0.9% saline 0.45% albumin.
•
Venous
and arterial catheters, either central or peripheral.
•
Two
20mL syringes and 3-way taps.
•
Blood
administration set and warming coils.
•
Calibrated
waste blood container.
•
+/–
High flow rate infusion pump.
•
Appropriately
cross-matched blood (see Indications).
•
ECG
and BP monitor.
•
Sterile
dressing pack (including gown, gauze swabs, drapes, and gloves).
•
If not
already present, insert central or peripheral venous/arterial catheters.
•
Start
continuous ECG and frequent BP monitoring.
•
As a
baseline, measure serum FBC, U&E, Ca2+, glucose, and blood
gases.
•
Prime blood
administration set and warm blood to 37°C.
•
Arrange
for an assistant to keep a constant accurate log of volumes removed and
replaced throughout the procedure.
•
Use a
full aseptic technique throughout the procedure.
•
Wash
hands and put on sterile gloves, gown, +/– surgical mask.
•
Connect
3-way taps into the system (exact arrangement depends on choice of method; see
the following bullet points).
•
If
using a single central venous catheter, e.g. UVC, use two sequential 3-way taps
to perform the following in order:
•
Withdraw
5–20mL blood from the baby using a syringe over
a few minutes.
•
Turn
first 3-way tap to allow blood to be syringed into a waste bag.
•
Turn
second 3-way tap to allow 5–20mL, fresh, warmed blood to be drawn from pack.
•
Turn
tap and syringe fresh blood slowly
into baby (2–3min).
•
If
using two catheters together, remove 5–20mL aliquots of blood from the central
or arterial catheter over 5–10min and then turn a single 3-way tap to allow
blood to be pushed into the waste bag. Simultaneously, the same volume of fresh
warmed blood is infused into the patient via the other venous catheter using a
high rate flow infusion pump.
•
A safe
volume to remove each turn varies depending on size of infant. Remove 5mL
aliquots for ELBW infants, increasing up to 20mL for full term infants.
•
Apart
from continuously monitoring pulse, ECG, BP, and temperature, every 30–60min
during the procedure measure blood gases, FBC, U&E, serum Ca2+,
and glucose. Measure again at the end of the procedure, as well as a
coagulation profile. Correct any abnormality found.
•
Once
procedure is completed, leave catheters in place in case repeat exchange
transfusion is required.
•
Catheter-induced
thrombotic or embolic phenomenon, e.g. portal vein thrombosis or NEC.
•
Haemodynamic
compromise, e.g. cardiac arrhythmia or hypotension.
•
Metabolic,
e.g. hypoglycaemia (transfused plasma often has a low blood glucose
concentration due to red cell consumption), hypokalaemia, hypocalcaemia, hypomagnesaemia,
acidaemia.
•
Coagulopathy
or thrombocytopenia.
•
Hypothermia.
•
Infection: bacteraemia, HIV, CMV, hepatitis B
or C. Blood must be screened prior to
transfusion.
•
Graft vs. host disease: risk reduced by irradiation or
leucocyte filtration.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.